BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3500922)

  • 1. Cytogenetic studies on human myeloma cell lines.
    Jernberg H; Zech L; Nilsson K
    Int J Cancer; 1987 Dec; 40(6):811-7. PubMed ID: 3500922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of G banded karyotypes in myeloma cells.
    Chen KC; Bevan PC; Matthews JG
    J Clin Pathol; 1986 Mar; 39(3):260-6. PubMed ID: 3457025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Karyotypic variability of human myeloma cell lines].
    Turilova VK; Smirnova TD
    Tsitologiia; 2012; 54(8):621-36. PubMed ID: 23074853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Metaphase chromosomes of human multiple myeloma cells of line U-266: karyotype and morpho-functional characteristics of nucleolar organizer regions].
    Turilova VI; Pendina AA; Smirnova TD
    Tsitologiia; 2003; 45(6):606-13. PubMed ID: 14521092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytogenetic and biological characterization of two new human plasma cell lines.
    Brox LW; Belch A; Pollock E; He XX; De Braekeleer M; Lin CC
    Cancer Genet Cytogenet; 1987 Jul; 27(1):135-44. PubMed ID: 3472643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cytogenetic study of multiple myeloma].
    Zhang Y; Jiang B; Huang XJ; Shi Y; He Q; Dang H; Qiu JY; Lu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Feb; 15(1):76-8. PubMed ID: 17490526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment and characterization of two human myeloma cell lines secreting kappa light chains.
    Eton O; Scheinberg DA; Houghton AN
    Leukemia; 1989 Oct; 3(10):729-35. PubMed ID: 2506399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosomes in plasma-cell malignancies.
    Van Den Berghe H
    Eur J Haematol Suppl; 1989; 51():47-51. PubMed ID: 2697595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of chromosome numerical changes in multiple myeloma: fluorescence in situ hybridization analysis using 15 chromosome-specific probes.
    Tabernero D; San Miguel JF; Garcia-Sanz M; Nájera L; García-Isidoro M; Peréz-Simon JA; Gonzalez M; Wiegant J; Raap AK; Orfão A
    Am J Pathol; 1996 Jul; 149(1):153-61. PubMed ID: 8686739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosomal aberrations of multiple myeloma in Chinese patients at diagnosis: a study by combined G-banding and multicolor spectral karyotyping.
    Ng MH; Wong N; Lau TT; Tsang KS; Cheng SH; Chan NP; Tang SH; Lei KI; Leung Y
    Oncol Rep; 2003; 10(3):587-91. PubMed ID: 12684628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The biology and cytogenetics of multiple myeloma.
    Ho PJ; Campbell LJ; Gibson J; Brown R; Joshua D
    Rev Clin Exp Hematol; 2002 Sep; 6(3):276-300. PubMed ID: 12616699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent immunoglobulin gene translocations identify distinct molecular subtypes of myeloma.
    Chesi M; Kuehl WM; Bergsagel PL
    Ann Oncol; 2000; 11 Suppl 1():131-5. PubMed ID: 10707795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonrandom karyotype abnormalities in 36 multiple myeloma patients.
    Ankathil R; Madhavan J; Gangadharan VP; Pillai GR; Nair MK
    Cancer Genet Cytogenet; 1995 Aug; 83(1):71-4. PubMed ID: 7656209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Der(16)t(1;16)(q10;p10) in multiple myeloma: a new non-random abnormality that is frequently associated with Burkitt's-type translocations.
    Mugneret F; Sidaner I; Favre B; Manone L; Maynadié M; Caillot D; Solary E
    Leukemia; 1995 Feb; 9(2):277-81. PubMed ID: 7869764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined spectral karyotyping, comparative genomic hybridization, and in vitro apoptyping of a panel of Burkitt's lymphoma-derived B cell lines reveals an unexpected complexity of chromosomal aberrations and a recurrence of specific abnormalities in chemoresistant cell lines.
    Karpova MB; Schoumans J; Blennow E; Ernberg I; Henter JI; Smirnov AF; Nordenskjöld M; Fadeel B
    Int J Oncol; 2006 Mar; 28(3):605-17. PubMed ID: 16465364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Karyotypic evolution in multiple myeloma.
    MacKenzie MR; Lewis JP
    Cancer Genet Cytogenet; 1985 Aug; 17(4):301-5. PubMed ID: 4016715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential analysis of chromosome aberrations in multiple myeloma during disease progression.
    Wu KL; Beverloo B; Velthuizen SJ; Sonneveld P
    Clin Lymphoma Myeloma; 2007 Jan; 7(4):280-5. PubMed ID: 17324335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diverse karyotypic abnormalities of the c-myc locus associated with c-myc dysregulation and tumor progression in multiple myeloma.
    Shou Y; Martelli ML; Gabrea A; Qi Y; Brents LA; Roschke A; Dewald G; Kirsch IR; Bergsagel PL; Kuehl WM
    Proc Natl Acad Sci U S A; 2000 Jan; 97(1):228-33. PubMed ID: 10618400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cytogenetic study in multiple myeloma. II. Clinical significance of chromosomal changes].
    Scudla V; Jarosová M; Kapustová M; Indrák K
    Vnitr Lek; 1990 Nov; 36(11):1081-91. PubMed ID: 2267738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cytogenetic study in multiple myeloma. I. Chromosome findings in 56 patients].
    Jarosová M; Scudla V; Indrák K; Kapustová M
    Vnitr Lek; 1990 Nov; 36(11):1072-80. PubMed ID: 2267737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.